Correlation between GenoType MTBDRplus Assay and Phenotypic Susceptibility Test for Prothionamide in Patients with Genotypic Isoniazid Resistance
Joo Hee Lee, Kyung-Wook Jo, Tae Sun Shim
Tuberc Respir Dis. 2019;82(2):143-150.   Published online 2018 Sep 28     DOI: https://doi.org/10.4046/trd.2018.0027
Citations to this article as recorded by Crossref logo
Delphi Survey on the Current and Future Korean Guidelines for Isoniazid-Monoresistant Tuberculosis
Wan Seo, Hyung Woo Kim, Eung Gu Lee, Tai Joon An, Seunghoon Kim, Yun-Jeong Jeong, Sang Haak Lee, Yeonhee Park, Jeongha Mok, Jee Youn Oh, Yousang Ko, Sun-Hyung Kim, Sun Jung Kwon, Sung Soo Jung, Jin Woo Kim, Ju Sang Kim, Jinsoo Min
Infection and Drug Resistance.2023; Volume 16: 5233.     CrossRef
Comparison of different regimens with or without fluoroquinolone in isoniazid-resistant tuberculosis: A multicenter cohort study
Jinsoo Min, Hyung Woo Kim, Ji Young Kang, Sung Kyoung Kim, Jin Woo Kim, Yong Hyun Kim, Hyoung Kyu Yoon, Sang Haak Lee, Ju Sang Kim, Vipa Thanachartwet
PLOS ONE.2022; 17(8): e0273263.     CrossRef
The Value of the inhA Mutation Detection in Predicting Ethionamide Resistance Using Melting Curve Technology
Yanhua Song, Guirong Wang, Qiang Li, Rongmei Liu, Liping Ma, Qi Li, Mengqiu Gao
Infection and Drug Resistance.2021; Volume 14: 329.     CrossRef